Optics11 Life

Optics11 Life, headquartered in The Netherlands, is a pioneering company founded in 2011 that delves into the mechanobiology of cells, tissues, hydrogels, and other soft biomaterials. The company offers a range of innovative solutions including PIUMA, CHIARO, and PAVONE, designed to provide real-time, non-destructive mechanical characterization of soft and living biomaterials. Their technology has garnered significant attention, evidenced by the recent $5.00M Venture Round investment from FORWARD.one and Value Creation Capital in September 29th, 2022. Optics11 Life's cutting-edge solutions play a crucial role in enhancing disease modeling, therapy development, and regenerative medicine by uncovering the ways in which mechanics influence the biology of cells and tissues. Their commitment to refining technology to seamlessly integrate into advanced labs, along with the ease of operation, optical readouts, and control of physiological parameters, sets them apart in the market. The company's clear understanding of the market and unique technology positions them as significant players in the field of mechanobiology, with the potential to drive impactful advancements in various scientific disciplines.